For the study, published in Nature Communications, the team described their framework, called DRIAD (Drug Repurposing In Alzheimer's Disease), which relies on machine learning -- a branch of artificial intelligence in which systems are 'trained' on vast amounts of data.
from Top Buzz News- News18.com https://ift.tt/3bnu4S2
No comments:
Post a Comment